FindTrial
Sign In

Chemotherapy for advanced non-small cell lung cancer with interstitial lung disease: systematic review and meta-analysis

Chemotherapy for advanced non-small cell lung cancer with interstitial lung disease: systematic review and meta-analysis - Chemotherapy for advanced non-small cell lung cancer with interstitial lung disease: systematic review and meta-analysis

Status
Active, not recruiting
Phases
Unknown
Study type
Unknown
Source
JPRN
Registry ID
JPRN-UMIN000018145
Enrollment
200
Registered
2015-07-01
Start date
2015-05-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

advanced non-small cell lung cancer with interstitial lung disease

Interventions

None listed

Sponsors

Hyogo Prefectural Amagasaki General Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients with interstitial lung disease and suffering from non small cell lung cancer. Treated with chemotherapy.

Exclusion criteria

Exclusion criteria: treated with epidermal growth factor receptor tyrosine-kinase inhibitor

Design outcomes

Primary

MeasureTime frame
One year survival—

Countries

Japan

Contacts

Public ContactKATAOKA Yuki

Hyogo Prefectural Amagasaki General Medical Center Department of Respiratory Medicine, Hospital Care Research Unit

hanshin.crt@gmail.com06-6480-7000

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026